372 related articles for article (PubMed ID: 19036499)
21. The antitumor immune responses induced by nanoemulsion-encapsulated MAGE1-HSP70/SEA complex protein vaccine following peroral administration route.
Ge W; Li Y; Li ZS; Zhang SH; Sun YJ; Hu PZ; Wang XM; Huang Y; Si SY; Zhang XM; Sui YF
Cancer Immunol Immunother; 2009 Feb; 58(2):201-8. PubMed ID: 18523770
[TBL] [Abstract][Full Text] [Related]
22. Tumor cells with B7.1 and transmembrane anchored staphylococcal enterotoxin A generate effective antitumor immunity.
Si SY; Hu PZ; Huang YY; Ye J; Huang Y; Li ZS; Ge W; Li X; Qu P; Zhang XM; Sui YF
Biochem Biophys Res Commun; 2006 Aug; 347(1):208-14. PubMed ID: 16814254
[TBL] [Abstract][Full Text] [Related]
23. MHC-matched corneal allograft rejection in an IFN-gamma/IL-17-independent manner in C57BL/6 mice.
Yamada J; Hamuro J; Fukushima A; Ohteki T; Terai K; Iwakura Y; Yagita H; Kinoshita S
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2139-46. PubMed ID: 19136699
[TBL] [Abstract][Full Text] [Related]
24. Gene transfer preferentially selects MHC class I positive tumour cells and enhances tumour immunogenicity.
Hacker UT; Schildhauer I; Barroso MC; Kofler DM; Gerner FM; Mysliwietz J; Buening H; Hallek M; King SB
Cancer Immunol Immunother; 2006 May; 55(5):547-57. PubMed ID: 16044254
[TBL] [Abstract][Full Text] [Related]
25. Heat shock proteins HSP70 and GP96: structural insights.
Facciponte JG; Wang XY; MacDonald IJ; Park JE; Arnouk H; Grimm MJ; Li Y; Kim H; Manjili MH; Easton DP; Subjeck JR
Cancer Immunol Immunother; 2006 Mar; 55(3):339-46. PubMed ID: 16032399
[TBL] [Abstract][Full Text] [Related]
26. B lymphocytes and macrophages release cell membrane deposited C3-fragments on exosomes with T cell response-enhancing capacity.
Papp K; Végh P; Prechl J; Kerekes K; Kovács J; Csikós G; Bajtay Z; Erdei A
Mol Immunol; 2008 Apr; 45(8):2343-51. PubMed ID: 18192019
[TBL] [Abstract][Full Text] [Related]
27. Immunization with heat shock protein 70 from methylcholanthrene-induced sarcomas induces tumor protection correlating with in vitro T cell responses.
Ciupitu AM; Petersson M; Kono K; Charo J; Kiessling R
Cancer Immunol Immunother; 2002 May; 51(3):163-70. PubMed ID: 11941455
[TBL] [Abstract][Full Text] [Related]
28. The effect of vaccination with the lysate of heat-shocked tumor cells on nitric oxide production in BALB/c mice with fibrosarcoma tumor.
Hashemi SM; Hassan ZM; Soudi S; Shahabi S
Cell Biol Int; 2008 Jul; 32(7):835-40. PubMed ID: 18455932
[TBL] [Abstract][Full Text] [Related]
29. Induction of heat shock proteins in B-cell exosomes.
Clayton A; Turkes A; Navabi H; Mason MD; Tabi Z
J Cell Sci; 2005 Aug; 118(Pt 16):3631-8. PubMed ID: 16046478
[TBL] [Abstract][Full Text] [Related]
30. Induction of a tumour-specific CTL response by exosomes isolated from heat-treated malignant ascites of gastric cancer patients.
Zhong H; Yang Y; Ma S; Xiu F; Cai Z; Zhao H; Du L
Int J Hyperthermia; 2011; 27(6):604-11. PubMed ID: 21846196
[TBL] [Abstract][Full Text] [Related]
31. The induction of tumor-specific CD4+ T cells via major histocompatibility complex class II is required to gain optimal anti-tumor immunity against B16 melanoma cell line in tumor immunotherapy using dendritic cells.
Fujisawa Y; Nabekura T; Nakao T; Nakamura Y; Takahashi T; Kawachi Y; Otsuka F; Onodera M
Exp Dermatol; 2009 Apr; 18(4):396-403. PubMed ID: 19054057
[TBL] [Abstract][Full Text] [Related]
32. A broadly applicable, personalized heat shock protein-mediated oncolytic tumor vaccine.
Huang XF; Ren W; Rollins L; Pittman P; Shah M; Shen L; Gu Q; Strube R; Hu F; Chen SY
Cancer Res; 2003 Nov; 63(21):7321-9. PubMed ID: 14612530
[TBL] [Abstract][Full Text] [Related]
33. Co-segregation of tumor immunogenicity with expression of inducible but not constitutive hsp70 in rat colon carcinomas.
Ménoret A; Patry Y; Burg C; Le Pendu J
J Immunol; 1995 Jul; 155(2):740-7. PubMed ID: 7608552
[TBL] [Abstract][Full Text] [Related]
34. Allogeneic melanoma vaccine expressing alphaGal epitopes induces antitumor immunity to autologous antigens in mice without signs of toxicity.
Rossi GR; Mautino MR; Awwad DZ; Husske K; Lejukole H; Koenigsfeld M; Ramsey WJ; Vahanian N; Link CJ
J Immunother; 2008; 31(6):545-54. PubMed ID: 18528300
[TBL] [Abstract][Full Text] [Related]
35. Targeting tumor antigens to secreted membrane vesicles in vivo induces efficient antitumor immune responses.
Zeelenberg IS; Ostrowski M; Krumeich S; Bobrie A; Jancic C; Boissonnas A; Delcayre A; Le Pecq JB; Combadière B; Amigorena S; Théry C
Cancer Res; 2008 Feb; 68(4):1228-35. PubMed ID: 18281500
[TBL] [Abstract][Full Text] [Related]
36. Tumor-specific immunogenicity of stress-induced proteins: convergence of two evolutionary pathways of antigen presentation?
Srivastava PK; Heike M
Semin Immunol; 1991 Jan; 3(1):57-64. PubMed ID: 1893123
[TBL] [Abstract][Full Text] [Related]
37. [Antitumor therapeutic effect induced by intestine-carcinoma cells vaccine expressing membrane-bound heat shock protein 70].
Huang CX; Yu H; Yang GG; Wang QQ; Shen FP; Li D; Cao XT
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):255-8. PubMed ID: 16167242
[TBL] [Abstract][Full Text] [Related]
38. Cancer genesis: stem tumour cells as an MHC-null/HSP70 - very high 'primordial self' escaping both MHC-restricted and MHC-non- restricted immunesurveillance.
Manzo G
Med Hypotheses; 2001 Jun; 56(6):724-30. PubMed ID: 11399124
[TBL] [Abstract][Full Text] [Related]
39. Artificial exosomes as tools for basic and clinical immunology.
De La Peña H; Madrigal JA; Rusakiewicz S; Bencsik M; Cave GW; Selman A; Rees RC; Travers PJ; Dodi IA
J Immunol Methods; 2009 May; 344(2):121-32. PubMed ID: 19345222
[TBL] [Abstract][Full Text] [Related]
40. Exosomes: a new delivery system for tumor antigens in cancer immunotherapy.
Cho JA; Yeo DJ; Son HY; Kim HW; Jung DS; Ko JK; Koh JS; Kim YN; Kim CW
Int J Cancer; 2005 Apr; 114(4):613-22. PubMed ID: 15609328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
